← 產業報告目錄

Radiology AI Market by Offering (On-Device, SaaS), Function (Triage, Workflow, CDSS, Acquisition, Processing, Reporting), Modality (CT, MRI, X-ray), Indication (Onco, Cardio, Neuro), End User (Hospital, Imaging Center), Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-11-20頁數 347報告編號 HIT9593

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The radiology AI market is projected to reach USD 2.27 billion by 2030 from USD 0.76 billion in 2025, at a CAGR of 24.5%. The growth is fueled by the increasing adoption of AI-driven diagnostic tools for early cancer detection, lesion segmentation, and predictive treatment planning, which enhance diagnostic accuracy and reduce radiologist workload. The expanding application of these solutions in oncology, neuroimaging, and cardiovascular imaging is significantly boosting demand for intelligent AI platforms capable of delivering real-time insights, personalized diagnostics, and workflow optimization, creating a high-value opportunity in the healthcare technology landscape. The workflow optimization segment is expected to witness significant market share during the forecast period. Based on the function, the radiology AI market is segmented into screening & triage, diagnostic imaging & interpretation (image acquisition, reconstruction & enhancement, image processing, analysis & detection, clinical decision support, others), treatment planning & intervention support (dose planning & optimization, surgical planning & guidance, image-based segmentation & anatomical modeling, others), monitoring & follow-up, reporting & documentation, workflow optimization, research & clinical development, and others. Workflow optimization is projected to record the fastest CAGR in the radiology AI market, driven by its strong economic and operational impact across imaging departments. With global radiologist shortages and rising imaging volumes, health systems are prioritizing AI that enhances productivity through intelligent worklist orchestration and automated case routing, as well as real-time modality utilization and turnaround-time reduction. These solutions streamline communication between technologists and radiologists, reduce the need for repeat scans, facilitate protocol standardization, and help eliminate manual administrative tasks. As hospitals increasingly shift toward value-based care, workflow AI directly supports cost containment, faster patient throughput, and an improved patient experience, making it a key investment area over the forecast period. The software/SaaS segment is expected to have the largest share in 2025 in the radiology AI market. By offering, the software/SaaS solutions segment is expected to hold the largest market share in 2025, primarily because they are easier to deploy, update, and scale across multiple imaging modalities. These platforms seamlessly integrate with existing Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and Electronic Health Record (EHR) systems, enabling radiologists to access AI insights directly within their routine workflows without requiring major infrastructure changes. Cloud-based architectures enhance accessibility, support continuous model improvement, and lower upfront capital expenditure. Additionally, software vendors leverage subscription and usage-based pricing, making adoption budget-friendly while driving strong recurring revenue. Growing regulatory approvals for diagnostic AI tools, along with strong use cases in oncology, neurology, and cardiology, further accelerate the dominance of this technology in the market. The North America region accounted for a substantial share of the radiology AI market in 2025. The North American region accounted for a substantial share of the radiology AI market in 2025, driven by significant investments in healthcare infrastructure, the adoption of advanced technology, and high demand for imaging services. The US, in particular, has seen widespread integration of AI into radiology workflows, supported by federal incentives for digital health adoption and regulatory approvals for AI-powered diagnostic tools. In addition, the growing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has increased the demand for advanced imaging solutions, fueling the adoption of AI algorithms for image analysis, triage, and workflow optimization. For instance, in April 2025, according to the NIHCM Foundation, chronic diseases continue to pose a major burden on the US healthcare system, accounting for approximately 90% of the USD 4.5 trillion spent on healthcare in 2022, affecting around 60% of people in the US with multiple chronic conditions, thus driving high costs and complex care needs. Robust investment from both private and public sectors, along with a high concentration of AI startups and established technology companies, further reinforced North American market leadership. Companies such as Aidoc (US), Enlitic, Inc. (US), and GE HealthCare (US) are actively developing AI-enabled platforms for CT, MRI, X-ray, and PET imaging, enhancing diagnostic accuracy and operational efficiency. However, challenges such as data privacy concerns under HIPAA and clinician hesitancy to fully adopt AI tools remain. Despite these hurdles, the region continues to lead the global radiology AI market due to a combination of advanced healthcare infrastructure, favorable reimbursement policies, high R&D investment, and early adoption of innovative AI technologies. These factors collectively reinforce North America’s leadership in the radiology AI market. The breakdown of primary participants is as mentioned below: • By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25% • By Designation – C Level: 40%, Director Level: 30%, and Others: 30% • By Region - North America: 40%, Europe: 30%, Asia Pacific: 25%, Latin America: 3%, Middle East & Africa: 2% Key Players in the Radiology AI Market The key players functioning in the radiology AI market include Siemens Healthineers AG (Germany), Microsoft (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), Fujifilm Holdings Corporation (Japan), Canon Medical Systems Corporation (Japan), Merative (US), DeepHealth (RadNet, Inc.) (US), Shanghai United Imaging Healthcare Co., LTD (China), Hologic, Inc. (US), and Enlitic, Inc. (US). Research Coverage: The report analyses the radiology AI market. It aims to estimate the market size and future growth potential of various market segments based on offering, function, modality, indication, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report This report will help established firms and new entrants/smaller firms gauge the market's pulse, which, in turn, will help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market. This report provides insights into:  Analysis of key drivers: Drivers (increasing medical imaging volumes, rising demand for AI solutions to alleviate radiologist workload, increase in regulatory clarity, accelerated approvals and government support, growing demand for AI-driven radiological image processing, growing funding for AI-focused startups, and rising collaborations with AI, tech, and analytics solution providers, Restraints (high implementation costs and ROI uncertainty, regulatory fragmentation across regions, and data quality and label scarcity for rarer indications), Opportunities (Growing demand for platform, multi-modal data, and OEM integration [PACS/EHR/marketplaces], untapped growth potential in emerging healthcare markets, expansion of preventive care and population health management, and expansion of portable or handheld devices with AI integration), Challenges (integration challenges with legacy radiology systems, limited clinician trust and explainability demands, and concerns over data privacy and security) influencing the growth of the radiology AI market.  Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product launches in the radiology AI market  Market Development: Comprehensive information on the lucrative emerging markets, by offering, function, modality, indication, end user, and region.  Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the radiology AI market.  Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the radiology AI market such as Siemens Healthineers AG (Germany), Microsoft (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), Fujifilm Holdings Corporation (Japan), Canon Medical Systems Corporation (Japan), Merative (US), DeepHealth (RadNet, Inc.) (US), Shanghai United Imaging Healthcare Co., LTD (China), Hologic, Inc. (US), and Enlitic, Inc. (US).
目錄 Table of Contents
1 INTRODUCTION 27 1.1 STUDY OBJECTIVES 27 1.2 MARKET DEFINITION 27 1.3 STUDY SCOPE 28 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 28 1.3.2 INCLUSIONS & EXCLUSIONS 29 1.3.3 YEARS CONSIDERED 30 1.4 CURRENCY 30 1.5 STAKEHOLDERS 31 2 EXECUTIVE SUMMARY 32 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 32 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS & STRATEGIC DEVELOPMENTS 33 2.3 DISRUPTIVE TRENDS SHAPING MARKET 34 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 35 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 36 3 PREMIUM INSIGHTS 37 3.1 RADIOLOGY AI MARKET OVERVIEW 37 3.2 NORTH AMERICA: RADIOLOGY AI MARKET, BY OFFERING & COUNTRY 38 3.3 RADIOLOGY AI MARKET: GEOGRAPHIC SNAPSHOT 38 4 MARKET OVERVIEW 39 4.1 INTRODUCTION 39 4.2 MARKET DYNAMICS 39 4.2.1 DRIVERS 41 4.2.1.1 Increasing medical imaging volumes 41 4.2.1.2 Rising demand for AI solutions to alleviate radiologist workload 42 4.2.1.3 Increased regulatory clarity, accelerated approvals, and government support 42 4.2.1.4 Growing demand for AI-driven radiological image processing 44 4.2.1.5 Growing funding for AI-focused startups 45 4.2.1.6 Rising collaborations with AI, tech, and analytics solution providers 45 4.2.2 RESTRAINTS 46 4.2.2.1 High implementation costs and ROI uncertainty 46 4.2.2.2 Regulatory fragmentation across regions 47 4.2.2.3 Data quality and label scarcity for rarer indications 48   4.2.3 OPPORTUNITIES 48 4.2.3.1 Growing demand for platform, multi-modal data, and OEM integration (PACS/EHR/marketplaces) 48 4.2.3.2 Untapped growth potential in emerging healthcare markets 49 4.2.3.3 Expansion of preventive care and population health management 50 4.2.3.4 Expansion of portable/handheld devices with AI integration 51 4.2.4 CHALLENGES 51 4.2.4.1 Integration challenges with legacy radiology systems 51 4.2.4.2 Limited clinician trust and explainability demands 52 4.2.4.3 Concerns over data privacy and security 53 4.3 UNMET NEEDS & WHITE SPACES 56 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 57 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 57 5 INDUSTRY TRENDS 59 5.1 PORTER’S FIVE FORCES ANALYSIS 59 5.1.1 BARGAINING POWER OF SUPPLIERS 60 5.1.2 BARGAINING POWER OF BUYERS 60 5.1.3 THREAT OF SUBSTITUTES 60 5.1.4 THREAT OF NEW ENTRANTS 60 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 61 5.2 MACROECONOMIC INDICATORS 61 5.2.1 INTRODUCTION 61 5.2.2 GDP TRENDS & FORECAST 61 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 61 5.3 SUPPLY CHAIN ANALYSIS 61 5.4 ECOSYSTEM ANALYSIS 63 5.5 PRICING ANALYSIS 65 5.5.1 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY OFFERING (2024) 66 5.5.2 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY REGION (2024) 66 5.6 KEY CONFERENCES & EVENTS, 2026–2027 67 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 68 5.8 INVESTMENT & FUNDING SCENARIO 69 5.9 CASE STUDY ANALYSIS 69 5.10 IMPACT OF 2025 US TARIFFS ON RADIOLOGY AI MARKET 70 5.10.1 INTRODUCTION 70 5.10.2 KEY TARIFF RATES 71 5.10.3 PRICE IMPACT ANALYSIS 72 5.10.4 IMPACT ON COUNTRY/REGION 72 5.10.4.1 US 72 5.10.4.2 Europe 72 5.10.4.3 Asia Pacific 73 5.10.5 IMPACT ON END-USE INDUSTRIES 73 5.10.5.1 Hospitals & healthcare systems 73 5.10.5.2 Diagnostic imaging centers & independent radiology practices 73 5.10.5.3 Academic, research, and life science institutions 74 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 75 6.1 KEY EMERGING TECHNOLOGIES 75 6.1.1 GENERATIVE AI FOR IMAGE RECONSTRUCTION 75 6.1.2 MULTIMODAL AI INTEGRATION 75 6.1.3 FEDERATED LEARNING FRAMEWORKS 76 6.2 COMPLEMENTARY TECHNOLOGIES 76 6.2.1 CLOUD-BASED IMAGING PLATFORMS 76 6.2.2 BLOCKCHAIN FOR DATA INTEGRITY & TRACEABILITY 77 6.2.3 ADVANCED VISUALIZATION & AR/VR TOOLS 77 6.3 TECHNOLOGY/PRODUCT ROADMAP 78 6.4 PATENT ANALYSIS 78 6.4.1 PATENT PUBLICATION TRENDS FOR RADIOLOGY AI MARKET 79 6.4.2 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 79 6.5 FUTURE APPLICATIONS 82 6.5.1 AI-DRIVEN PRECISION RADIOLOGY & PERSONALIZED TREATMENT PLANNING 82 6.5.2 AUTONOMOUS IMAGING & WORKFLOW ORCHESTRATION 82 6.5.3 PREDICTIVE & PREVENTIVE DIAGNOSTIC PLATFORMS 83 7 REGULATORY LANDSCAPE 84 7.1 REGIONAL REGULATIONS & COMPLIANCE 84 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 7.1.2 REGULATORY FRAMEWORK 89 7.1.2.1 North America 89 7.1.2.2 Europe 90 7.1.2.3 Asia Pacific 90 7.1.2.4 Latin America 92 7.1.2.5 Middle East & Africa 92 7.1.3 INDUSTRY STANDARDS 92 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 94 8.1 DECISION-MAKING PROCESS 94 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 94 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 94 8.2.2 BUYING CRITERIA 95 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 96 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 97 8.4.1 UNMET NEEDS 97 8.4.2 END-USER EXPECTATIONS 98 8.5 MARKET PROFITABILITY 99 9 RADIOLOGY AI MARKET, BY OFFERING 100 9.1 INTRODUCTION 101 9.2 ON-DEVICE SOFTWARE 101 9.2.1 RISING DEMAND FOR REAL-TIME, SECURE, AND LOW-LATENCY DIAGNOSTIC INTELLIGENCE TO ACCELERATE ADOPTION 101 9.3 SOFTWARE/SAAS 102 9.3.1 GROWING DEMAND FOR SCALABLE, COST-EFFICIENT, CLOUD-BASED RADIOLOGY AI TO SUPPORT MARKET GROWTH 102 10 RADIOLOGY AI MARKET, BY FUNCTION 104 10.1 INTRODUCTION 105 10.2 SCREENING & TRIAGE 106 10.2.1 RISING NEED FOR RAPID IDENTIFICATION AND PRIORITIZATION OF CRITICAL FINDINGS TO DRIVE ADOPTION OF SCREENING & TRIAGE AI 106 10.3 DIAGNOSTIC IMAGING & INTERPRETATION 106 10.3.1 GROWING DEMAND FOR HIGHER DIAGNOSTIC ACCURACY AND WORKLOAD REDUCTION TO ACCELERATE ADOPTION 106 10.4 TREATMENT PLANNING & INTERVENTION SUPPORT 107 10.4.1 RISING DEMAND FOR PRECISE, PERSONALIZED TREATMENT PLANNING TO SUPPORT MARKET GROWTH 107 10.5 MONITORING & FOLLOW-UP 108 10.5.1 RISING NEED FOR QUANTITATIVE, LONG-TERM DISEASE MONITORING TO BOOST MARKET GROWTH 108 10.6 REPORTING & DOCUMENTATION 109 10.6.1 GROWING NEED FOR STANDARDIZED, AUTOMATED RADIOLOGY REPORTING TO CONTRIBUTE TO GROWTH 109 10.7 WORKFLOW OPTIMIZATION 110 10.7.1 RISING NEED FOR EFFICIENT, AUTOMATED RADIOLOGY WORKFLOWS TO FUEL GROWTH 110 10.8 RESEARCH & CLINICAL DEVELOPMENT 111 10.8.1 GROWING DEMAND FOR AI-ACCELERATED IMAGING RESEARCH TO PROPEL MARKET 111 10.9 OTHER FUNCTIONS 112 11 RADIOLOGY AI MARKET, BY MODALITY 113 11.1 INTRODUCTION 114 11.2 CT 115 11.2.1 GROWING NEED FOR FASTER, MORE ACCURATE CT DIAGNOSIS TO DRIVE MARKET GROWTH 115   11.3 MRI 116 11.3.1 ONGOING TECHNOLOGICAL ADVANCEMENTS IN MRI TECHNOLOGY TO SUPPORT GROWTH 116 11.4 X-RAY 116 11.4.1 GROWING NEED TO MANAGE RISING IMAGING VOLUMES TO DRIVE DEMAND FOR AI-ENHANCED X-RAY SYSTEMS 116 11.5 ULTRASOUND 117 11.5.1 ADVANTAGES SUCH AS MINIMALLY INVASIVE NATURE, LOW COST, AND ABSENCE OF IONIZING RADIATION TO BOOST ADOPTION 117 11.6 MAMMOGRAPHY 118 11.6.1 RISING BREAST CANCER BURDEN TO DRIVE AI ADOPTION IN MAMMOGRAPHY 118 11.7 OTHER MODALITIES 119 12 RADIOLOGY AI MARKET, BY INDICATION 120 12.1 INTRODUCTION 121 12.2 ONCOLOGY 121 12.2.1 RISING GLOBAL CANCER BURDEN TO ACCELERATE NEED FOR AI-DRIVEN DIAGNOSTICS 121 12.3 CARDIOLOGY 122 12.3.1 GROWING CARDIOVASCULAR DISEASE PREVALENCE TO BOOST ADOPTION OF CARDIAC IMAGING AI 122 12.4 NEUROLOGY 123 12.4.1 INCREASING STROKE AND NEURODEGENERATIVE CASES TO DRIVE RAPID AI INTEGRATION 123 12.5 PULMONOLOGY/RESPIRATORY DISEASES 124 12.5.1 EXPANDING LUNG DISEASE INCIDENCE TO FUEL DEMAND FOR AI-BASED DETECTION 124 12.6 ORTHOPEDICS 125 12.6.1 RISING TRAUMA AND OSTEOARTHRITIS CASES TO INCREASE NEED FOR MSK AI 125 12.7 WOMEN’S HEALTH 126 12.7.1 GROWING BREAST CANCER SCREENING VOLUMES TO ACCELERATE AI-ENABLED IMAGING ADOPTION 126 12.8 OTHER INDICATIONS 127 13 RADIOLOGY AI MARKET, BY END USER 128 13.1 INTRODUCTION 129 13.2 HOSPITALS 129 13.2.1 INCREASING DEPLOYMENT OF ADVANCED RADIOLOGY AI-ENABLED IMAGING SYSTEMS IN HOSPITALS TO DRIVE MARKET GROWTH 129 13.3 DIAGNOSTIC IMAGING CENTERS 130 13.3.1 RISING VOLUME OF IMAGING PROCEDURES TO STRENGTHEN NEED FOR AI-SUPPORTED IMAGE INTERPRETATION 130 13.4 OTHER END USERS 131 14 RADIOLOGY AI MARKET, BY REGION 133 14.1 INTRODUCTION 134 14.2 NORTH AMERICA 134 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 136 14.2.2 US 139 14.2.2.1 US to dominate global radiology AI market 139 14.2.3 CANADA 142 14.2.3.1 Growing integration of AI in radiology supported by strong research & regulatory frameworks to drive market 142 14.3 EUROPE 145 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 146 14.3.2 GERMANY 148 14.3.2.1 Growing need to advance diagnostic precision through AI-driven imaging to boost market 148 14.3.3 FRANCE 151 14.3.3.1 Need to address regulatory, ethical, and integration challenges in France’s radiology AI market to boost growth 151 14.3.4 UK 154 14.3.4.1 Accelerating AI integration in diagnostic imaging across NHS to spur market growth 154 14.3.5 ITALY 157 14.3.5.1 Regulatory complexity and infrastructure gaps to constrain radiology AI expansion 157 14.3.6 SPAIN 160 14.3.6.1 Advancing digital imaging and AI integration across Spain’s healthcare system to support growth 160 14.3.7 REST OF EUROPE 163 14.4 ASIA PACIFIC 165 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 167 14.4.2 JAPAN 169 14.4.2.1 Strong digital health infrastructure and government-led innovation programs to support growth 169 14.4.3 CHINA 172 14.4.3.1 Rapid adoption and scale-up of AI-enabled radiology in China to drive growth 172 14.4.4 INDIA 176 14.4.4.1 Rising imaging volumes and need for scalable diagnostic solutions to fuel growth 176 14.4.5 SOUTH KOREA 179 14.4.5.1 Integration and validation challenges in South Korea’s radiology AI market to slow growth 179 14.4.6 AUSTRALIA 182 14.4.6.1 Scaling clinical AI from pilot programs to nationwide deployment to boost market 182 14.4.7 REST OF ASIA PACIFIC 184 14.5 LATIN AMERICA 187 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 188 14.5.2 BRAZIL 191 14.5.2.1 Expanding clinical integration and local innovation in radiology AI to fuel market 191 14.5.3 MEXICO 193 14.5.3.1 Integration and regulatory barriers to hinder AI adoption in radiology 193 14.5.4 REST OF LATIN AMERICA 196 14.6 MIDDLE EAST & AFRICA 199 14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 199 14.6.2 GCC COUNTRIES 202 14.6.2.1 Saudi Arabia 205 14.6.2.1.1 Advancing diagnostic intelligence through healthcare digitalization and AI integration to fuel growth 205 14.6.2.2 UAE 209 14.6.2.2.1 Accelerating smart healthcare transformation through AI-enabled radiology to spur growth 209 14.6.2.3 Rest of GCC Countries 212 14.6.3 SOUTH AFRICA 214 14.6.3.1 Growing integration of AI to strengthen diagnostic imaging and clinical efficiency 214 14.6.4 REST OF MIDDLE EAST & AFRICA 217 15 COMPETITIVE LANDSCAPE 221 15.1 OVERVIEW 221 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 221 15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOLOGY AI MARKET 221 15.3 REVENUE ANALYSIS, 2020–2024 224 15.4 MARKET SHARE ANALYSIS, 2024 225 15.5 BRAND/SOFTWARE COMPARISON 227 15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 228 15.6.1 STARS 228 15.6.2 EMERGING LEADERS 228 15.6.3 PERVASIVE PLAYERS 228 15.6.4 PARTICIPANTS 228 15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 230 15.6.5.1 Company footprint 230 15.6.5.2 Region footprint 231 15.6.5.3 Offering footprint 231 15.6.5.4 Function footprint 232 15.6.5.5 Modality footprint 233 15.6.5.6 End-user footprint 234   15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 235 15.7.1 PROGRESSIVE COMPANIES 235 15.7.2 RESPONSIVE COMPANIES 235 15.7.3 DYNAMIC COMPANIES 235 15.7.4 STARTING BLOCKS 235 15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 237 15.7.5.1 Detailed list of key startups/SMEs 237 15.7.5.2 Competitive benchmarking of startups/SMEs 238 15.8 COMPANY VALUATION & FINANCIAL METRICS 240 15.8.1 FINANCIAL METRICS 240 15.8.2 COMPANY VALUATION 241 15.9 COMPETITIVE SCENARIO 241 15.9.1 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS 241 15.9.2 DEALS 242 15.9.3 OTHER DEVELOPMENTS 243 15.10 KEY PLAYERS 244 15.10.1 SIEMENS HEALTHINEERS AG 244 15.10.1.1 Business overview 244 15.10.1.2 Solutions offered 245 15.10.1.3 Recent developments 247 15.10.1.3.1 Product launches 247 15.10.1.3.2 Deals 247 15.10.1.3.3 Other developments 249 15.10.1.4 MnM view 250 15.10.1.4.1 Right to win 250 15.10.1.4.2 Strategic choices 250 15.10.1.4.3 Weaknesses & competitive threats 250 15.10.2 MICROSOFT 251 15.10.2.1 Business overview 251 15.10.2.2 Solutions offered 252 15.10.2.3 Recent developments 253 15.10.2.3.1 Product launches 253 15.10.2.3.2 Deals 254 15.10.2.3.3 Other developments 255 15.10.2.4 MnM view 255 15.10.2.4.1 Right to win 255 15.10.2.4.2 Strategic choices 256 15.10.2.4.3 Weaknesses & competitive threats 256 15.10.3 KONINKLIJKE PHILIPS N.V. 257 15.10.3.1 Business overview 257 15.10.3.2 Solutions offered 259 15.10.3.3 Recent developments 261 15.10.3.3.1 Product launches & approvals 261 15.10.3.3.2 Deals 262 15.10.3.3.3 Other developments 263 15.10.3.4 MnM view 264 15.10.3.4.1 Right to win 264 15.10.3.4.2 Strategic choices 264 15.10.3.4.3 Weaknesses & competitive threats 264 15.10.4 GE HEALTHCARE 265 15.10.4.1 Business overview 265 15.10.4.2 Solutions offered 266 15.10.4.3 Recent developments 267 15.10.4.3.1 Product launches & approvals 267 15.10.4.3.2 Deals 268 15.10.4.3.3 Expansions 270 15.10.4.3.4 Other developments 270 15.10.4.4 MnM view 271 15.10.4.4.1 Right to win 271 15.10.4.4.2 Strategic choices 271 15.10.4.4.3 Weaknesses & competitive threats 271 15.10.5 FUJIFILM HOLDINGS CORPORATION 272 15.10.5.1 Business overview 272 15.10.5.2 Solutions offered 273 15.10.5.3 Recent developments 276 15.10.5.3.1 Product launches & approvals 276 15.10.5.3.2 Deals 276 15.10.5.3.3 Other developments 277 15.10.5.4 MnM view 277 15.10.5.4.1 Right to win 277 15.10.5.4.2 Strategic choices 278 15.10.5.4.3 Weaknesses & competitive threats 278 15.10.6 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.) 279 15.10.6.1 Business overview 279 15.10.6.2 Solutions offered 280 15.10.6.3 Recent developments 281 15.10.6.3.1 Product launches & approvals 281 15.10.6.3.2 Deals 282 15.10.6.3.3 Other developments 282 15.10.7 MERATIVE 283 15.10.7.1 Business overview 283 15.10.7.2 Solutions offered 284 15.10.7.3 Recent developments 285 15.10.7.3.1 Deals 285 15.10.7.3.2 Expansions 286 15.10.7.3.3 Other developments 287 15.10.8 RADNET, INC. (DEEPHEALTH) 288 15.10.8.1 Business overview 288 15.10.8.2 Solutions offered 289 15.10.8.3 Recent developments 291 15.10.8.3.1 Product launches & approvals 291 15.10.8.3.2 Deals 292 15.10.9 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. 293 15.10.9.1 Business overview 293 15.10.9.2 Solutions offered 294 15.10.9.3 Recent developments 295 15.10.9.3.1 Product launches & approvals 295 15.10.9.3.2 Deals 296 15.10.9.3.3 Other developments 296 15.10.10 HOLOGIC, INC. 298 15.10.10.1 Business overview 298 15.10.10.2 Solutions offered 299 15.10.10.3 Recent developments 300 15.10.10.3.1 Product launches & approvals 300 15.10.10.3.2 Deals 301 15.10.10.3.3 Other developments 301 15.10.11 ENLITIC, INC. 303 15.10.11.1 Business overview 303 15.10.11.2 Solutions offered 304 15.10.11.3 Recent developments 305 15.10.11.3.1 Product launches & approvals 305 15.10.11.3.2 Deals 305 15.10.11.3.3 Other developments 306 15.11 OTHER PLAYERS 307 15.11.1 AIDOC 307 15.11.2 VIZ.AI, INC. 308 15.11.3 NANOX 309 15.11.4 QURE.AI 310 15.11.5 ESAOTE S.P.A. 311 15.11.6 BUTTERFLY NETWORK INC. 312 15.11.7 HEARTFLOW INC. 313 15.11.8 SUBTLE MEDICAL, INC. 314 15.11.9 HARISSON.AI 315 15.11.10 ECHONOUS INC. 316 15.11.11 QUIBIM 317 15.11.12 IMAGEN 318 15.11.13 EXO IMAGING, INC. 319 15.11.14 RAD AI 320 16 RESEARCH METHODOLOGY 321 16.1 RESEARCH DATA 321 16.1.1 SECONDARY DATA 322 16.1.1.1 Key data from secondary sources 322 16.1.2 PRIMARY DATA 323 16.1.2.1 Key data from primary sources 324 16.1.2.2 Breakdown of primary sources 325 16.2 RESEARCH APPROACH 326 16.3 MARKET SIZE ESTIMATION 327 16.4 MARKET BREAKDOWN & DATA TRIANGULATION 334 16.5 RESEARCH ASSUMPTIONS 335 16.5.1 MARKET SIZING ASSUMPTIONS 335 16.5.2 OVERALL STUDY ASSUMPTIONS 335 16.6 RISK ASSESSMENT 336 16.7 RESEARCH LIMITATIONS 336 16.7.1 METHODOLOGY-RELATED LIMITATIONS 336 16.7.2 SCOPE-RELATED LIMITATIONS 336 17 APPENDIX 337 17.1 DISCUSSION GUIDE 337 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 342 17.3 CUSTOMIZATION OPTIONS 344 17.4 RELATED REPORTS 345 17.5 AUTHOR DETAILS 346
圖表清單 List of Tables & Figures
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 30 TABLE 2 RADIOLOGY AI MARKET: IMPACT ANALYSIS 40 TABLE 3 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011–2024 55 TABLE 4 RADIOLOGY AI MARKET: PORTER’S FIVE FORCES ANALYSIS 60 TABLE 5 RADIOLOGY AI MARKET: ROLE IN ECOSYSTEM 64 TABLE 6 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY OFFERING (2024) 66 TABLE 7 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY REGION (2024) 67 TABLE 8 RADIOLOGY AI MARKET: KEY CONFERENCES & EVENTS, 2026–2027 67 TABLE 9 CASE STUDY 1: PRINCESS ALEXANDRA HOSPITAL NHS TRUST: ENHANCING DIAGNOSTIC CONFIDENCE WITH INTEGRATED AI 69 TABLE 10 CASE STUDY 2: EMBRACING AI FOR EFFICIENT CHEST X-RAY REPORTING AND QUALITY ASSURANCE 70 TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 71 TABLE 12 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR RADIOLOGY AI MARKET 80 TABLE 13 RADIOLOGY AI MARKET: LIST OF PATENTS/PATENT APPLICATIONS 81 TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85 TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86 TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86 TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 19 REGULATORY SCENARIO OF NORTH AMERICA 89 TABLE 20 REGULATORY SCENARIO OF EUROPE 90 TABLE 21 REGULATORY SCENARIO OF ASIA PACIFIC 90 TABLE 22 REGULATORY SCENARIO OF LATIN AMERICA 92 TABLE 23 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 92 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%) 95 TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS 96 TABLE 26 UNMET NEEDS IN RADIOLOGY AI MARKET 97 TABLE 27 END-USER EXPECTATIONS IN RADIOLOGY AI MARKET 98 TABLE 28 RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 101 TABLE 29 RADIOLOGY AI MARKET FOR ON-DEVICE SOFTWARE, BY REGION, 2023–2030 (USD MILLION) 102 TABLE 30 RADIOLOGY AI MARKET FOR SOFTWARE/SAAS, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 31 RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 105 TABLE 32 RADIOLOGY AI MARKET FOR SCREENING & TRIAGE, BY REGION, 2023–2030 (USD MILLION) 106 TABLE 33 RADIOLOGY AI MARKET FOR DIAGNOSTIC IMAGING & INTERPRETATION, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 34 RADIOLOGY AI MARKET FOR TREATMENT PLANNING & INTERVENTION SUPPORT, BY REGION, 2023–2030 (USD MILLION) 108 TABLE 35 RADIOLOGY AI MARKET FOR MONITORING & FOLLOW-UP, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 36 RADIOLOGY AI MARKET FOR REPORTING & DOCUMENTATION, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 37 RADIOLOGY AI MARKET FOR WORKFLOW OPTIMIZATION, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 38 RADIOLOGY AI MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 39 RADIOLOGY AI MARKET FOR OTHER FUNCTIONS, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 40 RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 114 TABLE 41 RADIOLOGY AI MARKET FOR CT, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 42 RADIOLOGY AI MARKET FOR MRI, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 43 RADIOLOGY AI MARKET FOR X-RAY, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 44 RADIOLOGY AI MARKET FOR ULTRASOUND, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 45 RADIOLOGY AI MARKET FOR MAMMOGRAPHY, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 46 RADIOLOGY AI MARKET FOR OTHER MODALITIES, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 47 RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 121 TABLE 48 RADIOLOGY AI MARKET FOR ONCOLOGY, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 49 RADIOLOGY AI MARKET FOR CARDIOLOGY, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 50 RADIOLOGY AI MARKET FOR NEUROLOGY, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 51 RADIOLOGY AI MARKET FOR PULMONOLOGY/RESPIRATORY DISEASES, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 52 RADIOLOGY AI MARKET FOR ORTHOPEDICS, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 53 RADIOLOGY AI MARKET FOR WOMEN’S HEALTH, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 54 RADIOLOGY AI MARKET FOR OTHER INDICATIONS, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 55 RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 129 TABLE 56 RADIOLOGY AI MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 57 RADIOLOGY AI MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 58 RADIOLOGY AI MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 59 RADIOLOGY AI MARKET, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 60 NORTH AMERICA: RADIOLOGY AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 61 NORTH AMERICA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 137 TABLE 62 NORTH AMERICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 137 TABLE 63 NORTH AMERICA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 138 TABLE 64 NORTH AMERICA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 138 TABLE 65 NORTH AMERICA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 139 TABLE 66 US: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 140 TABLE 67 US: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 140 TABLE 68 US: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 141 TABLE 69 US: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 141 TABLE 70 US: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 142 TABLE 71 CANADA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 143 TABLE 72 CANADA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 143 TABLE 73 CANADA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 144 TABLE 74 CANADA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 144 TABLE 75 CANADA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 145 TABLE 76 EUROPE: RADIOLOGY AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 77 EUROPE: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 146 TABLE 78 EUROPE: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 147 TABLE 79 EUROPE: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 147 TABLE 80 EUROPE: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 148 TABLE 81 EUROPE: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 148 TABLE 82 GERMANY: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 149 TABLE 83 GERMANY: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 149 TABLE 84 GERMANY: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 150 TABLE 85 GERMANY: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 150 TABLE 86 GERMANY: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 151 TABLE 87 FRANCE: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 152 TABLE 88 FRANCE: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 152 TABLE 89 FRANCE: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 153 TABLE 90 FRANCE: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 153 TABLE 91 FRANCE: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 92 UK: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 155 TABLE 93 UK: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 155 TABLE 94 UK: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 156 TABLE 95 UK: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 156 TABLE 96 UK: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 157 TABLE 97 ITALY: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 158 TABLE 98 ITALY: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 158 TABLE 99 ITALY: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 159 TABLE 100 ITALY: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 159 TABLE 101 ITALY: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 102 SPAIN: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 161 TABLE 103 SPAIN: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 161 TABLE 104 SPAIN: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 162 TABLE 105 SPAIN: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 162 TABLE 106 SPAIN: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 107 REST OF EUROPE: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 163 TABLE 108 REST OF EUROPE: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 164 TABLE 109 REST OF EUROPE: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 164 TABLE 110 REST OF EUROPE: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 165 TABLE 111 REST OF EUROPE: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 165 TABLE 112 ASIA PACIFIC: RADIOLOGY AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 113 ASIA PACIFIC: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 167 TABLE 114 ASIA PACIFIC: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 168 TABLE 115 ASIA PACIFIC: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 168 TABLE 116 ASIA PACIFIC: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 169 TABLE 117 ASIA PACIFIC: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 169 TABLE 118 JAPAN: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 170 TABLE 119 JAPAN: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 171 TABLE 120 JAPAN: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 171 TABLE 121 JAPAN: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 172 TABLE 122 JAPAN: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 123 CHINA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 173 TABLE 124 CHINA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 174 TABLE 125 CHINA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 174 TABLE 126 CHINA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 175 TABLE 127 CHINA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 128 INDIA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 176 TABLE 129 INDIA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 177 TABLE 130 INDIA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 177 TABLE 131 INDIA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 178 TABLE 132 INDIA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 178 TABLE 133 SOUTH KOREA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 179 TABLE 134 SOUTH KOREA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 180 TABLE 135 SOUTH KOREA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 180 TABLE 136 SOUTH KOREA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 181 TABLE 137 SOUTH KOREA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 181 TABLE 138 AUSTRALIA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 182 TABLE 139 AUSTRALIA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 183 TABLE 140 AUSTRALIA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 183 TABLE 141 AUSTRALIA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 184 TABLE 142 AUSTRALIA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 184 TABLE 143 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 185 TABLE 144 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 185 TABLE 145 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 186 TABLE 146 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 186 TABLE 147 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 148 LATIN AMERICA: RADIOLOGY AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 149 LATIN AMERICA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 188 TABLE 150 LATIN AMERICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 189 TABLE 151 LATIN AMERICA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 189 TABLE 152 LATIN AMERICA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 190 TABLE 153 LATIN AMERICA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 190 TABLE 154 BRAZIL: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 191 TABLE 155 BRAZIL: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 192 TABLE 156 BRAZIL: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 192 TABLE 157 BRAZIL: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 193 TABLE 158 BRAZIL: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 193 TABLE 159 MEXICO: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 194 TABLE 160 MEXICO: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 194 TABLE 161 MEXICO: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 195 TABLE 162 MEXICO: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 195 TABLE 163 MEXICO: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 196 TABLE 164 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 197 TABLE 165 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 197 TABLE 166 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 198 TABLE 167 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 198 TABLE 168 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 199 TABLE 169 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 170 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 200 TABLE 171 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 201 TABLE 172 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 201 TABLE 173 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 202 TABLE 174 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 202 TABLE 175 GCC COUNTRIES: RADIOLOGY AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 176 GCC COUNTRIES: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 203 TABLE 177 GCC COUNTRIES: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 204 TABLE 178 GCC COUNTRIES: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 204 TABLE 179 GCC COUNTRIES: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 205 TABLE 180 GCC COUNTRIES: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 205 TABLE 181 SAUDI ARABIA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 206 TABLE 182 SAUDI ARABIA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 207 TABLE 183 SAUDI ARABIA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 207 TABLE 184 SAUDI ARABIA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 208 TABLE 185 SAUDI ARABIA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 208 TABLE 186 UAE: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 209 TABLE 187 UAE: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 210 TABLE 188 UAE: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 210 TABLE 189 UAE: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 211 TABLE 190 UAE: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 211 TABLE 191 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 212 TABLE 192 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 213 TABLE 193 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 213 TABLE 194 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 214 TABLE 195 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 214 TABLE 196 SOUTH AFRICA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 215 TABLE 197 SOUTH AFRICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 215 TABLE 198 SOUTH AFRICA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 216 TABLE 199 SOUTH AFRICA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 216 TABLE 200 SOUTH AFRICA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 217 TABLE 201 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY OFFERING, 2023–2030 (USD MILLION) 218 TABLE 202 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 218 TABLE 203 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY MODALITY, 2023–2030 (USD MILLION) 219 TABLE 204 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY INDICATION, 2023–2030 (USD MILLION) 219 TABLE 205 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY END USER, 2023–2030 (USD MILLION) 220 TABLE 206 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOLOGY AI MARKET, JANUARY 2022–NOVEMBER 2025 221 TABLE 207 RADIOLOGY AI MARKET: DEGREE OF COMPETITION 226 TABLE 208 RADIOLOGY AI MARKET: REGION FOOTPRINT 231 TABLE 209 RADIOLOGY AI MARKET: OFFERING FOOTPRINT 231 TABLE 210 RADIOLOGY AI MARKET: FUNCTION FOOTPRINT 232 TABLE 211 RADIOLOGY AI MARKET: MODALITY FOOTPRINT 233 TABLE 212 RADIOLOGY AI MARKET: END-USER FOOTPRINT 234 TABLE 213 RADIOLOGY AI MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 237 TABLE 214 RADIOLOGY AI MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS AND SMES, BY REGION 238 TABLE 215 RADIOLOGY AI MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS AND SMES, BY MODALITY 239 TABLE 216 RADIOLOGY AI MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS AND SMES, BY END USER 240 TABLE 217 RADIOLOGY AI MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2022–NOVEMBER 2025 241 TABLE 218 RADIOLOGY AI MARKET: DEALS, JANUARY 2022–NOVEMBER 2025 242 TABLE 219 RADIOLOGY AI MARKET: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 243 TABLE 220 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 244 TABLE 221 SIEMENS HEALTHINEERS AG: SOLUTIONS OFFERED 245 TABLE 222 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 247 TABLE 223 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–NOVEMBER 2025 247 TABLE 224 SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 249 TABLE 225 MICROSOFT: COMPANY OVERVIEW 251 TABLE 226 MICROSOFT: SOLUTIONS OFFERED 252 TABLE 227 MICROSOFT: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 253 TABLE 228 MICROSOFT: DEALS, JANUARY 2022–NOVEMBER 2025 254 TABLE 229 MICROSOFT: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 255 TABLE 230 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 257 TABLE 231 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED 259 TABLE 232 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025 261 TABLE 233 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–NOVEMBER 2025 262 TABLE 234 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 263 TABLE 235 GE HEALTHCARE: COMPANY OVERVIEW 265 TABLE 236 GE HEALTHCARE: SOLUTIONS OFFERED 266 TABLE 237 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025 267 TABLE 238 GE HEALTHCARE: DEALS, JANUARY 2022–NOVEMBER 2025 268 TABLE 239 GE HEALTHCARE: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 270 TABLE 240 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 270 TABLE 241 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 272 TABLE 242 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED 273 TABLE 243 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025 276 TABLE 244 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2022–NOVEMBER 2025 276 TABLE 245 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 277 TABLE 246 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): COMPANY OVERVIEW 279 TABLE 247 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): SOLUTIONS OFFERED 280 TABLE 248 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025 281 TABLE 249 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): DEALS, JANUARY 2022–NOVEMBER 2025 282 TABLE 250 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 282 TABLE 251 MERATIVE: COMPANY OVERVIEW 283 TABLE 252 MERATIVE: SOLUTIONS OFFERED 284 TABLE 253 MERATIVE: DEALS, JANUARY 2022–NOVEMBER 2025 285 TABLE 254 MERATIVE: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 286 TABLE 255 MERATIVE: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 287 TABLE 256 RADNET, INC. (DEEPHEALTH): COMPANY OVERVIEW 288 TABLE 257 RADNET, INC. (DEEPHEALTH): SOLUTIONS OFFERED 289 TABLE 258 RADNET, INC. (DEEPHEALTH): PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025 291 TABLE 259 RADNET, INC. (DEEPHEALTH): DEALS, JANUARY 2022–NOVEMBER 2025 292 TABLE 260 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW 293 TABLE 261 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: SOLUTIONS OFFERED 294 TABLE 262 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025 295 TABLE 263 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: DEALS, JANUARY 2022–NOVEMBER 2025 296 TABLE 264 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 296 TABLE 265 HOLOGIC, INC.: COMPANY OVERVIEW 298 TABLE 266 HOLOGIC, INC.: SOLUTIONS OFFERED 299 TABLE 267 HOLOGIC, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025 300 TABLE 268 HOLOGIC, INC. : DEALS, JANUARY 2022–NOVEMBER 2025 301 TABLE 269 HOLOGIC, INC.: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 301 TABLE 270 ENLITIC, INC.: COMPANY OVERVIEW 303 TABLE 271 ENLITIC, INC.: SOLUTIONS OFFERED 304 TABLE 272 ENLITIC, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025 305 TABLE 273 ENLITIC, INC.: DEALS, JANUARY 2022–NOVEMBER 2025 305 TABLE 274 ENLITIC, INC.: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 306 TABLE 275 AIDOC: COMPANY OVERVIEW 307 TABLE 276 VIZ.AI, INC.: COMPANY OVERVIEW 308 TABLE 277 NANOX: COMPANY OVERVIEW 309 TABLE 278 QURE.AI: COMPANY OVERVIEW 310 TABLE 279 ESAOTE S.P.A.: COMPANY OVERVIEW 311 TABLE 280 BUTTERFLY NETWORK INC.: COMPANY OVERVIEW 312 TABLE 281 HEARTFLOW, INC.: COMPANY OVERVIEW 313 TABLE 282 SUBTLE MEDICAL, INC.: COMPANY OVERVIEW 314 TABLE 283 HARISSON.AI: COMPANY OVERVIEW 315 TABLE 284 ECHONOUS INC.: COMPANY OVERVIEW 316 TABLE 285 QUIBIM: COMPANY OVERVIEW 317 TABLE 286 IMAGEN: COMPANY OVERVIEW 318 TABLE 287 EXO IMAGING, INC.: COMPANY OVERVIEW 319 TABLE 288 RAD AI: COMPANY OVERVIEW 320 TABLE 289 FACTOR ANALYSIS 331 TABLE 290 RISK ASSESSMENT: RADIOLOGY AI MARKET 336 FIGURE 1 RADIOLOGY AI MARKET SEGMENTATION & REGIONAL SCOPE 28 FIGURE 2 MARKET SCENARIO 32 FIGURE 3 GLOBAL RADIOLOGY AI MARKET, 2023–2030 33 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOLOGY AI MARKET, 2020–2025 33 FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF RADIOLOGY AI MARKET 34 FIGURE 6 HIGH-GROWTH SEGMENTS IN RADIOLOGY AI MARKET, 2025–2030 35 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN RADIOLOGY AI MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 36 FIGURE 8 RISING IMAGING VOLUMES TO DRIVE GROWTH IN RADIOLOGY AI MARKET 37 FIGURE 9 SOFTWARE/SAAS SEGMENT IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 38 FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 38 FIGURE 11 RADIOLOGY AI MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 39 FIGURE 12 FDA-APPROVED AI-ENABLED RADIOLOGY (2019–MAY 2025) 43 FIGURE 13 PROVEN ACCURACY RATES OF AI IN DIAGNOSTIC IMAGING 44 FIGURE 14 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024 53 FIGURE 15 US: MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR, 2009–2024 54 FIGURE 16 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023 54 FIGURE 17 RADIOLOGY AI MARKET: PORTER’S FIVE FORCES ANALYSIS 59 FIGURE 18 RADIOLOGY AI MARKET: SUPPLY CHAIN ANALYSIS (2024) 62 FIGURE 19 RADIOLOGY AI MARKET: ECOSYSTEM ANALYSIS 64 FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 68 FIGURE 22 PATENT PUBLICATION TRENDS IN RADIOLOGY AI MARKET, 2015–2025 79 FIGURE 23 JURISDICTION & TOP APPLICANT ANALYSIS FOR RADIOLOGY AI MARKET 79 FIGURE 24 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR RADIOLOGY AI MARKET (JANUARY 2015 TO NOVEMBER 2025) 80 FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 95 FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS 96 FIGURE 27 NORTH AMERICA: RADIOLOGY AI MARKET SNAPSHOT 136 FIGURE 28 ASIA PACIFIC: RADIOLOGY AI MARKET SNAPSHOT 166 FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN RADIOLOGY AI MARKET, 2020–2024 (USD MILLION) 224 FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN RADIOLOGY AI MARKET (2024) 225 FIGURE 31 RADIOLOGY AI MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 227 FIGURE 32 RADIOLOGY AI MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 229 FIGURE 33 RADIOLOGY AI MARKET: COMPANY FOOTPRINT 230 FIGURE 34 RADIOLOGY AI MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 236 FIGURE 35 EV/EBITDA OF KEY VENDORS 240 FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 241 FIGURE 37 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 245 FIGURE 38 MICROSOFT: COMPANY SNAPSHOT 252 FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 258 FIGURE 40 GE HEALTHCARE: COMPANY SNAPSHOT 266 FIGURE 41 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 273 FIGURE 42 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): COMPANY SNAPSHOT 280 FIGURE 43 RADNET, INC. (DEEPHEALTH): COMPANY SNAPSHOT 289 FIGURE 44 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY SNAPSHOT 293 FIGURE 45 HOLOGIC, INC.: COMPANY SNAPSHOT 299 FIGURE 46 ENLITIC, INC.: COMPANY SNAPSHOT 304 FIGURE 47 RESEARCH DESIGN 321 FIGURE 48 PRIMARY SOURCES 323 FIGURE 49 INSIGHTS FROM INDUSTRY EXPERTS 325 FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 325 FIGURE 51 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 326 FIGURE 52 SUPPLY-SIDE MARKET ESTIMATION 328 FIGURE 53 RADIOLOGY AI MARKET: REVENUE ESTIMATION APPROACH 328 FIGURE 54 BOTTOM-UP APPROACH: END-USER SPENDING ON RADIOLOGY AI 330 FIGURE 55 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 332 FIGURE 56 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 333 FIGURE 57 TOP-DOWN APPROACH 333 FIGURE 58 DATA TRIANGULATION METHODOLOGY 334

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們